Parnax Lab [PARNAXLAB] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison
Parnax Lab
BSE
Loading...
Sun Pharmaceutical
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Parnax Lab wins in 6 metrics, Sun Pharmaceutical wins in 13 metrics, with 0 ties. Sun Pharmaceutical appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Parnax Lab | Sun Pharmaceutical | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 12.99 | 38.23 | Parnax Lab |
| Price-to-Book Ratio | 1.69 | 5.50 | Parnax Lab |
| Debt-to-Equity Ratio | 83.52 | 3.26 | Sun Pharmaceutical |
| PEG Ratio | -0.73 | -1.96 | Sun Pharmaceutical |
| EV/EBITDA | 8.04 | 24.38 | Parnax Lab |
| Profit Margin (TTM) | 5.67% | 19.29% | Sun Pharmaceutical |
| Operating Margin (TTM) | 10.29% | 24.34% | Sun Pharmaceutical |
| EBITDA Margin (TTM) | 10.29% | 24.34% | Sun Pharmaceutical |
| Return on Equity | 13.84% | 15.08% | Sun Pharmaceutical |
| Return on Assets (TTM) | 6.07% | 11.87% | Sun Pharmaceutical |
| Free Cash Flow (TTM) | $137.24M | $119.44B | Sun Pharmaceutical |
| Dividend Yield | N/A | 1.26% | N/A |
| 1-Year Return | 10.65% | -12.15% | Parnax Lab |
| Price-to-Sales Ratio (TTM) | 0.74 | 7.39 | Parnax Lab |
| Enterprise Value | $2.07B | $3,740.05B | Sun Pharmaceutical |
| EV/Revenue Ratio | 1.09 | 6.96 | Parnax Lab |
| Gross Profit Margin (TTM) | 43.83% | 79.58% | Sun Pharmaceutical |
| Revenue per Share (TTM) | $166 | $224 | Sun Pharmaceutical |
| Earnings per Share (Diluted) | $9.43 | $43.34 | Sun Pharmaceutical |
| Beta (Stock Volatility) | 0.46 | 0.31 | Sun Pharmaceutical |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Parnax Lab vs Sun Pharmaceutical Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Parnax Lab | 4.48% | 6.15% | 9.38% | 43.81% | 42.55% | -21.14% |
| Sun Pharmaceutical | -3.35% | -1.56% | -5.93% | -4.47% | -2.81% | -15.28% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Parnax Lab | 10.65% | 44.25% | 647.19% | 397.20% | 828.12% | 1,483.33% |
| Sun Pharmaceutical | -12.15% | 84.04% | 212.28% | 86.58% | 827.66% | 2,617.44% |
Performance & Financial Health Analysis: Parnax Lab vs Sun Pharmaceutical
| Metric | PARNAXLAB | SUNPHARMA |
|---|---|---|
| Market Information | ||
| Market Cap | ₹1.41B | ₹3.97T |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 5,491 | 1,917,026 |
| 90 Day Avg. Volume | 6,550 | 2,155,089 |
| Last Close | ₹133.00 | ₹1,601.20 |
| 52 Week Range | ₹81.00 - ₹193.50 | ₹1,553.05 - ₹1,960.35 |
| % from 52W High | -31.27% | -18.32% |
| All-Time High | ₹193.50 (Nov 04, 2024) | ₹1,960.35 (Sep 30, 2024) |
| % from All-Time High | -31.27% | -18.32% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.07% | 0.10% |
| Quarterly Earnings Growth | -0.18% | -0.20% |
| Financial Health | ||
| Profit Margin (TTM) | 0.06% | 0.19% |
| Operating Margin (TTM) | 0.10% | 0.24% |
| Return on Equity (TTM) | 0.14% | 0.15% |
| Debt to Equity (MRQ) | 83.52 | 3.26 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹72.57 | ₹300.99 |
| Cash per Share (MRQ) | ₹2.34 | ₹108.88 |
| Operating Cash Flow (TTM) | ₹297.41M | ₹110.84B |
| Levered Free Cash Flow (TTM) | ₹115.19M | ₹109.29B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.26% |
| Last 12-Month Dividend | N/A | ₹21.00 |
Valuation & Enterprise Metrics Analysis: Parnax Lab vs Sun Pharmaceutical
| Metric | PARNAXLAB | SUNPHARMA |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 12.99 | 38.23 |
| Forward P/E | N/A | 50.69 |
| PEG Ratio | -0.73 | -1.96 |
| Price to Sales (TTM) | 0.74 | 7.39 |
| Price to Book (MRQ) | 1.69 | 5.50 |
| Market Capitalization | ||
| Market Capitalization | ₹1.41B | ₹3.97T |
| Enterprise Value | ₹2.07B | ₹3.74T |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.09 | 6.96 |
| Enterprise to EBITDA | 8.04 | 24.38 |
| Risk & Other Metrics | ||
| Beta | 0.46 | 0.31 |
| Book Value per Share (MRQ) | ₹72.57 | ₹300.99 |
Financial Statements Comparison: Parnax Lab vs Sun Pharmaceutical
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | PARNAXLAB | SUNPHARMA |
|---|---|---|
| Revenue/Sales | ₹533.76M | ₹137.86B |
| Cost of Goods Sold | ₹299.82M | ₹28.15B |
| Gross Profit | ₹233.94M | ₹109.71B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹54.94M | ₹33.72B |
| EBITDA | ₹76.21M | ₹47.66B |
| Pre-Tax Income | ₹44.55M | ₹31.73B |
| Income Tax | ₹11.80M | ₹8.70B |
| Net Income (Profit) | ₹32.75M | ₹22.93B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | PARNAXLAB | SUNPHARMA |
|---|---|---|
| Cash & Equivalents | ₹5.50M | ₹102.69B |
| Total Current Assets | ₹683.40M | ₹526.24B |
| Total Current Liabilities | ₹743.34M | ₹181.94B |
| Long-Term Debt | ₹262.42M | ₹3.58B |
| Total Shareholders Equity | ₹832.42M | ₹724.86B |
| Retained Earnings | N/A | ₹578.62B |
| Property, Plant & Equipment | ₹1.09B | ₹100.36B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | PARNAXLAB | SUNPHARMA |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | PARNAXLAB | SUNPHARMA |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 5,491 | 1,917,026 |
| Average Daily Volume (90 Day) | 6,550 | 2,155,089 |
| Shares Outstanding | 11.49M | 2.40B |
| Float Shares | 2.99M | 1.04B |
| % Held by Insiders | 0.74% | 0.56% |
| % Held by Institutions | 0.00% | 0.25% |
Dividend Analysis & Yield Comparison: Parnax Lab vs Sun Pharmaceutical
| Metric | PARNAXLAB | SUNPHARMA |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹21.00 |
| Last 12-Month Dividend Yield | N/A | 1.26% |
| 3-Year Avg Annual Dividend | N/A | ₹14.67 |
| 3-Year Avg Dividend Yield | N/A | 0.46% |
| 3-Year Total Dividends | N/A | ₹44.00 |
| Ex-Dividend Date | N/A | Jul 07, 2025 |